Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer’s Disease

Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer's Disease Results presented at the 18th Clinical Trials in Alzheimer's Disease (CTAD) meeting, San Diego, December 1-4 GlobeNewswire December 02, 2025 VNA-318, an oral brain-penetrant small molecule therapeutic modulates a novel target to reduce inflammation and improve mitochondrial function First-in-human […]

BuySellVouchers Launches Holiday Sale: Save Up to 30% When Buying Gift Cards With Crypto

BuySellVouchers Launches Holiday Sale: Save Up to 30% When Buying Gift Cards With Crypto GlobeNewswire December 02, 2025 MANILA, Philippines, Dec. 02, 2025 (GLOBE NEWSWIRE) — BuySellVouchers, the global digital marketplace for gift cards has announced its biggest promotion of the year: holiday savings of up to 30% on select gift cards when purchased using

Biel Crystal donates HK$10 million to support Hong Kong Tai Po Fire relief

A major fire recently occurred at WongFook Court in Tai Po, Hong Kong, causing significant casualties and property damage, which has touched the hearts of people from all walks of life. Biel Crystal Holdings Limited donates HK$10 million for emergency relief and post-disaster reconstruction efforts. The donation will be used through official channels to ensure

Tuvalor Exchange Introduces New Transparency & Reporting Initiative for Global Users

Tuvalor Exchange has introduced a comprehensive Transparency & Reporting Initiative, expanding the platform's commitment to open communication, operational clarity, and user-centered accountability. This initiative strengthens Tuvalor's long-term objective of delivering a more visible, predictable, and responsibly managed digital asset environment for users worldwide. https://mma.prnewswire.com/media/2836158/Tuvalor_Exchange.jpg Enhancing Platform Clarity Through Structured Information Disclosure The new framework formalizes

Taiwan Design Week 2025 Explores How We Can Design NEXT

The third edition of Taiwan Design Week returns from 29 November to 7 December 2025, inviting global visitors to explore how design can shape a shared future. Organized by the Taiwan Design Research Institute (TDRI) and held at Songshan Cultural and Creative Park, this year's theme-DESIGN NEXT-examines how design responds to social, technological, and environmental

Proforma reporting of Essity’s new business areas

Effective January 1, 2026,Essity's business areas will be as follows: Health & Medical, Personal Care, Consumer Tissue and Professional Hygiene.The new business areas reflect the organizational change being made to accelerate the company's growth rate and more rapidly achieve its financial targets.Essity will report in accordance with the new structure as of the interim report

Bairong Announced HK$450 Million Share Repurchase Program

Bairong Inc. (the “Company”, “we” , “us” or “our” ; HKEX: 6608), a leading cloud-based AI turnkey service provider, announced a new HK$450 million share repurchase program. https://mma.prnewswire.com/media/1522592/WechatIMG64_Logo.jpg The Board of Directors of the Company wishes to announce that the Board resolved to repurchase Class B shares of the Company in the open market from

Bitget Supports Grassroots Football at LALIGA Youth Tournament in Manila

VICTORIA, Seychelles, Dec. 02, 2025 (GLOBE NEWSWIRE) — Bitget, the world's largest Universal Exchange (UEX), took part in LALIGA's Youth Tournament in Manila, supporting one of Asia's most exciting grassroots football events focused on promoting sport, community, and camaraderie. Held from 14-16 November at the New Clark City Athletics Stadium, the tournament brought together more

Enterome OncoMimics(TM) immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial

EO2401 in vivo immune therapy + nivolumab +/- bevacizumab shows survival benefit in first recurrent glioblastoma Data presented at 2025 SNO conference by lead investigator Paris, France – 2 DECEMBER 2025 (08:30 CET) Enterome, a clinical-stage company pioneering OncoMimics(TM) peptides, a new class of off-the-shelf, multi-targeted in vivo immune therapies that induce a fast and

Scroll to Top